Astea Pharma Holding IVS: Financial statements 2020
CVR: 39152576
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Astea Pharma Holding IVS (CVR 39152576) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -613 and a net result of DKK -613 compared with DKK -2,389 the year before. Equity in the 2020 report amounted to DKK -48,338.
- Revenue
- DKK 0
- Gross Profit
- DKK -613
- Profit/Loss
- DKK -613
- Equity
- DKK -48,338
- Total Assets
- DKK 302
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | -613 | -613 | -48 t. | - |
| 2019 | 0 | -2 t. | -2 t. | -48 t. | - |
| 2018 | 0 | -3 t. | -45 t. | -45 t. | - |
Official annual report
How creditworthy is Astea Pharma Holding IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Astea Pharma Holding IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -2,389.
About Astea Pharma Holding IVS
Astea Pharma Holding IVS was a Danish company of the type Iværksætterselskab based in København S, founded in 2017. The company has been dissolved on 3 June 2022. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2020, the company reported a gross profit of DKK -613 and a net result of DKK -613 compared with DKK -2,389 the year before. Equity in the 2020 report amounted to DKK -48,338.